**FAIL_UPHELD, narrowly; score 66/100.** No complete qualifying chain is demonstrated, so the frozen SPEC requires `FAIL_TO_ESTABLISH`. The evidence does **not** establish that public reconstruction is infeasible or that interactive user-side downloading is necessary. No critical issue found; unresolved high issues prevent closure at the required ≥90 threshold.

Read-only review completed. Both local CSVs were inspected **header only**; no count matrices or measurement values were opened.

1. **HIGH — R3 tests a stronger requirement than the frozen statistic needs.**  
   [SPEC.md:15](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/generations/sgen016/SPEC.md:15) explicitly requires an object declared as raw/guide-level counts. Thus, **the pre-committed screen really does require raw counts**; processed LFC evidence cannot retrospectively satisfy it.

   But [scientific_protocol_v1.json:17](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/lock_s/scientific_protocol_v1.json:17) defines the Sanger calculation using selected-library, model-level Table-6 LFC vectors, followed by within-panel ranking and donor averaging. Guide-count refitting is explicitly outside that route at line 63. Appropriate processed vectors, feature mappings, donor/model linkage, and the frozen covariates can suffice for that calculation. Raw counts become indispensable for a **normalization/refitting sensitivity**, not merely reconstruction of the processed-data statistic.

   R3 follows the target’s explicit raw-input ambition, but the SPEC conflates two feasibility questions. Preserve its failure verdict and distinguish those questions in any successor design.

2. **HIGH — The access conclusion exceeds the verified access failures.**  
   [screen_v1.json:8](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/generations/sgen016/screen_v1.json:8) says “all listing endpoints”; line 31 implies interactive access is necessary. The artifact provides no exhaustive endpoint inventory supporting either claim.

   There is a staff-documented `/portal/api/no-captcha/download/files` catalogue, announced live on July 28, 2026. Its proposed schema deliberately omitted download URLs, so catalogue discovery would not itself complete R3. **My current fetch also returned verification HTML**, supporting a present access obstacle without proving universal scriptable unavailability. [DepMap staff announcement](https://forum.depmap.org/t/provide-an-open-endpoint-for-latest-version-retrieval/4652), [current endpoint response](https://depmap.org/portal/api/no-captcha/download/files).

   Release-name download links are additional discovery candidates, not demonstrated working downloads. The public portal implementation shows that `/download/all/` redirects to the data page; a different URL spelling is therefore no guarantee of independent access. [Portal implementation](https://raw.githubusercontent.com/broadinstitute/depmap-portal/master/portal-backend/depmap/download/views.py).

   Stopping a bounded probe without bypassing verification was reasonable. Claiming the alternatives were exhausted was not.

3. **HIGH — The consequences overclaim infeasibility and prescribe an inconsistent remedy.**  
   [screen_v1.json:33](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/generations/sgen016/screen_v1.json:33) changes “not established” into “remains infeasible.” It then requires downloading **processed LFC/Chronos vectors**, although those would still fail its raw-count requirement.

   Nothing demonstrated makes a user-side download necessary. A successor manifest probe could resolve provenance before any outcome access. Likewise, “never independent confirmation” is too categorical as a statement about every future resource/design; the justified restriction concerns the present exploratory route and previously exposed evidence.

   The NextGen source also needs current interpretation: DepMap staff reported on October 14 that its temporary **Data Explorer dataset** was removed after incorporation into 26Q3. That does not establish removal of the manuscript download file set, nor does harmonized 26Q3 processing establish derivation equivalence. [DepMap staff clarification](https://forum.depmap.org/t/organoid-dependency-data/4671/7).

4. **MEDIUM — The field matrix does not audit every required semantic field.**  
   [SPEC.md:11](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/generations/sgen016/SPEC.md:11) promises individual field classifications, but the result gives group-level prose. It leaves sample-column mapping, feature namespace, donor deduplication, processing declarations, and provenance fields insufficiently traceable to particular sources.

   The SPEC also omits substantial parts of the [target definition:13](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/reviews/xhigh_next_targets_v2.md:13): condition/eligibility, controls and replication, pooling, feature/build versions, recipe hashes, and compute requirements. Some may be unnecessary for an unchanged processed-data route, but that requires an explicit dependency analysis. Their omission weakens the advertised coverage of the Rank-1 target.

5. **MEDIUM — `patient_chain_complete_count: 0` is defensible only as a verified-evidence count.**  
   With no qualifying raw object/sample map established, the number of **demonstrated complete chains** is zero under the SPEC. That is sufficient to fail.

   Header-only inspection cannot establish the number of biologically available patients, successful joins, or recoverable derivation chains. Those counts remain **unassessed**. The field should identify its meaning, for example `verified_complete_patient_chains: 0`, and distinguish unknown candidate coverage.

6. **MEDIUM — R2 understates one schema and overinterprets another.**  
   [screen_v1.json:12](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/generations/sgen016/screen_v1.json:12) omits the crosswalk’s actual `sample_ID` column. Together with `sanger_ID` and `individual_ID`, it provides plausible sample/model/donor linkage fields.

   Conversely, the Passports header’s `parent_id` does **not**, without documented semantics and populated records, establish a parent-specimen derivation chain. `model_type`, `model_comments`, and `model_relations_comment` are further potential provenance fields. The appropriate status is “candidate linkage schema present; semantics, joins, completeness, and uniqueness unverified.” Neither patient linkage nor its absence follows from column names alone.

7. **MEDIUM — R1 and R5 confuse inaccessible evidence with absent properties.**  
   A 403 or verification response establishes that a particular request failed. It does not establish absent provenance, controlled-access requirements, a charge, or unavailable public data. Use `NOT_VERIFIED_ACCESS_BLOCKED` or equivalent for these observations.

   Figshare public access is supported. “None observed” is appropriately cautious about charges, but does not establish the entire proposed route’s access and execution requirements.

8. **MEDIUM — Version coverage and request provenance are not reproducible from the screen artifact.**  
   The saved Figshare response identifies **version 1**. The result does not record a versions-list response, exact portal endpoints, response types, or supporting metadata hashes. This matters because M1 explicitly includes versions.

   I could not independently retrieve the versions API through the available web tool. Consequently, **no version >1 is established**, and no claim that a later version contains raw objects is warranted. The defensible inventory statement is version-specific; later-version coverage remains unverified.

9. **MEDIUM — “Frozen recipe” identity is asserted without binding evidence in the reviewed material.**  
   [scientific_protocol_v1.json:3](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/lock_s/scientific_protocol_v1.json:3) labels itself draft and says binding occurs through `LOCK2_COMMIT.json`. The target expressly requests definition/feature hashes, but the screen records neither a binding hash nor verification against that commit.

   This does not prove the protocol was never bound—the commit was outside this review’s supplied files. It means the screen has not demonstrated that prerequisite.

10. **LOW — Library identity is imprecisely reported.**  
    The protocol specifies **`minLib` else `v1_1`**, not simply “v1.” A `library` header establishes a field’s availability, not the selected values or their compatibility. Report the exact rule and distinguish schema presence from verified library assignments.

11. **LOW — Status vocabulary is inconsistent with the SPEC.**  
    `PARTIAL`, `PARTIAL+`, and `NOT_ESTABLISHABLE` are understandable, but differ from the promised `PRESENT/ABSENT/AMBIGUOUS` field classifications. Separate standardized status, evidence, and access-failure reason.

The **36-file inventory claim is correct**: one README, six metadata files, and 29 analysis files. The saved README explicitly identifies `minipool_chronos_gene_effects.csv` as processed Chronos scores. Guide/barcode metadata and sequencing QC totals are not raw guide-count matrices. No `EssMatrix`-named object appears in that inventory; objects elsewhere cannot be classified from that name alone. Public code separately references `minipool_readcounts.csv`, which is absent from the 36-file list—an additional input-discovery lead, not evidence of an accessible Sanger patient chain. [Public minipool processing code](https://raw.githubusercontent.com/broadinstitute/DepMap-NextGen-Public/main/src/generate.py).

**PARTIAL evidence cannot pass the frozen decision rule.** No reviewed evidence supplies the required patient→specimen→screened model→declared raw object chain with sample mapping, recipe, and access. The corrected consequence should say: “This bounded probe established no qualifying complete chain; public feasibility remains unresolved. No gate changes.”

SGEN016_VERDICT: FAIL_UPHELD
SGEN016_SCORE: 66